What is Calcivis?
Based in Edinburgh, United Kingdom, Calcivis is a specialized medical technology firm focused on the development of advanced imaging systems. The company's core innovation lies in its ability to identify active tooth decay at an early, sub-clinical stage. By providing dentists with real-time, actionable data, the platform enables the implementation of targeted preventive treatments, effectively shifting the paradigm from restorative intervention to proactive oral health management. This technology addresses a critical gap in the dental market, offering a high-precision solution that enhances patient outcomes while optimizing clinical workflows.
How much funding has Calcivis raised?
Calcivis has raised a total of $26.8M across 9 funding rounds:
Private Equity
$1.3M
Grant
$505K
Multiple Rounds
$13.2M
Private Equity
$1.3M
Other Financing Round
$2.2M
Unspecified
$2M
Other Financing Round
$6.3M
Private Equity (2014): $1.3M with participation from Archangel Informal Investment
Grant (2014): $505K, investors not publicly disclosed
Private Equity (2015): $7M supported by Archangel Investors
Grant (2015): $3M, investors not publicly disclosed
Other Financing Round (2015): $3.2M backed by European Commission
Private Equity (2017): $1.3M with participation from Archangel Investors and Julz Co, LLC
Other Financing Round (2019): $2.2M led by European Commission
Unspecified (2021): $2M supported by Scottish Enterprise, Lynx Financial, and Archangels
Other Financing Round (2024): $6.3M featuring Maven Capital Partners UK and Scottish National Investment Bank
Key Investors in Calcivis
Maven Capital Partners UK
Maven Capital Partners UK LLP is a prominent firm operating within the venture capital and private equity sectors, focusing on scaling innovative businesses.
Scottish National Investment Bank
A development investment bank providing long-term, patient capital to support sustainable economic growth and technological innovation across Scotland.
Archangel Investors
A prominent syndicate of angel investors known for providing early-stage and growth capital to high-potential technology companies in the United Kingdom.
What's next for Calcivis?
With the support of this major enterprise-level funding, Calcivis is expected to prioritize the broad-scale deployment of its imaging technology across key clinical markets. The strategic focus will likely shift toward enhancing manufacturing capabilities and strengthening commercial partnerships to ensure widespread adoption. As the company moves beyond the development phase, the integration of its diagnostic tools into routine dental examinations will be central to its long-term growth strategy. Investors are closely monitoring the firm's ability to translate its technological advantage into sustained market share within the global preventive dentistry landscape.
See full Calcivis company page
